Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York, founded in 1988 by physician-scientist Leonard S. Schleifer and researcher George D. Yancopoulos. It develops and manufactures medicines derived from its own antibody-discovery technology, including the eye disease treatment Eylea and the immunology drug Dupixent, and grew into one of the leading biotechnology companies in the United States.
Cross-Tradition Connections
Operates In
A major biotechnology company; classified in the atlas biotechnology-industry.
Reader Challenges (0 open reader challenges)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.
View At A Past Year
The atlas records no dated fact of its own for this entry, so there is no other year to choose.